Sfoglia per Rivista
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients who are primary non-responders or intolerant to infliximab: A real life multi-center experience of compassionate use
2008-01-01 Danese, S; Mocciaro, F; Guidi, L; Scribano, Ml; Comberlato, M; Vangeli, M; Pulitano, R; Manca, A; Armuzzi, A; Malesci, A; Prantera, C; Cottone, M
Surveillance of Barrett's Esophagus Post Ablation: Is It Better to Use Jumbo Over Standard Biopsy Forceps?
2016-01-01 Vennelaganti, S; Vennalaganti, P; Duvvuri, A; Lim, D; Jani, B; Repici, A; Ciscato, C; Spaggiari, P; Consolo, P; Di Leo, M; Mathur, S; Porter, J; Ferrara, E; Kennedy, K; Gupta, N; Sharma, P
SWITCHING FROM INFLIXIMAB ORIGINATOR TO CT-P13 IS NOT RELATED TO INCREASED IMMUNOGENICITY IN IBD PATIENTS: A PROSPECTIVE CASE-CONTROL STUDY
2017-01-01 Fiorino, G; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, Mf; Nagore, D; del Rio, L; Pascual, J; Martnez, A; Danese, S
Synchronous Cancerization Increases Metastatic Potential in MSS Colorectal Cancers (CRCs)
2012-01-01 Laghi, L; Fini, L; Basso, G; Bianchi, P; Delconte, G; Roncalli, M; Repici, A; Malesci, A
Systemic chemotherapy and two-stage hepatectomy in patients with extensive bilobar colorectal liver metastases: Perioperative safety and survival
2007-01-01 Chun, Ys; Vauthey, Jn; Ribero, D; Donadon, M; Eng, C; Brown, Td; Chang, Dz; Ho, L; Curley, Sa; Abdalla, Ek
Targeting SMAD7 in Crohn's Disease by Mongersen: Therapeutic Revolution Under Way?
2015-01-01 Danese, S; Fiorino, G; Peyrin-Biroulet, L.
Telaprevir for hepatitis C re-treatment: an open door on a long and winding road.
2010-01-01 Aghemo, A; Colombo, M.
Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!
2018-01-01 Jaboli, F; Pouillon, L; Bossuyt, P; Danese, S; Peyrin-Biroulet, L
The 5q31/IBD5 risk haplotype determines perianal phenotype in Crohn's disease
2002-01-01 Armuzzi, A; Ahmad, T; De Silva, Ap; Ling, K; Cullen, S; Van Heel, D; Jewell, D
The atypical chemokine receptor D6 controls intestinal inflammation and inflammation-associated colon cancer
2008-01-01 Vetrano, S.; Borroni, E.; Bonecchi, R.; Correale, C.; Arena, V.; Fantini, M.; Malesci, A.; Vecchi, A.; Mantovani, A.; Locati, M.; Danese, S.
THE EFFECTS OF VAGUS NERVE STIMULATION IN BIOLOGIC-REFRACTORY CROHN'S DISEASE: A PROSPECTIVE CLINICAL TRIAL
2018-01-01 D'Haens, Gr; Cabrijan, Z; Eberhardson, M; van den Berg, Rm; Lowenberg, M; Fiorino, G; Danese, S; Levine, Ya; Chernoff, D
The Golden Compass to the Depths
2016-01-01 Carrara, S; Di Leo, M; Zerbi, A
The impact of probiotics in antibiotic-associated diarrhea: A meta-analysis of placebo-controlled trials
2001-01-01 Cremonini, F; Di Caro, S; Bartolozzi, F; Armuzzi, A; Santarelli, L; Gabrielli, M; Colasanti, S; Pola, P; Gasbarrini, G; Gasbarrini, A
The intercellular adhesion molecule-1 polymorphisms in IBD
2002-01-01 Li, Jh; Yang, Xs; Cullen, S; Lin, Kl; Armuzzi, A; Ahmad, T; Neville, Mj; Walton, R; Jewell, D
The molecular classification of the clinical manifestations of Crohn's disease
2002-01-01 Ahmad, T; Armuzzi, A; Bunce, M; Mulcahy-Hawes, K; Marshall, Se; Orchard, Tr; Crawshaw, J; Large, O; De Silva, A; Cook, Jt; Barnardo, M; Cullen, S; Welsh, Ki; Jewell, Dp
The Prague Criteria Predict Response to Successful Endoscopic Eradication Therapy for Barrett's Esophagus With Dysplasia or Early Cancer: Results From an International, Multi-Center Consortium
2015-01-01 Konda, Vj; Repici, A; Gupta, N; Vennalaganti, P; Seewald, S; Olyaee, Ms; Buckles, Dc; Muthineni, S; Brown, J; Parasa, S; Bansal, A; Sharma, P
The PROSIT-BIO Cohort of the IG-IBD: A Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab BioSimilars
2016-01-01 Fiorino, G; Manetti, N; Variola, A; Bossa, F; Rizzuto, G; Armuzzi, A; Massari, A; Ghione, S; Cantoro, L; Lorenzon, G; Fries, W; Annunziata, Ml; Costa, F; Terpin, Mm; Principi, M; Cortelezzi, Cc; Biancone, L; Amato, A; Occhipinti, P; Mazzuoli, S; Ardizzone, S; Di Girolamo, M; Alvisi, P; Meucci, G; Caserta, L; Saibeni, S; Petruzzzellis, C; Ronchetti, A; Cappello, M; Castiglione, F; Danese, S; Massella, A; Varvara, D; Orlando, A; Annese, V
The thrombomodulin-activated protein C-endothelial protein C receptor pathway: A novel anti-inflammatory system in inflammatory bowel disease
2006-01-01 Danese, S; Scaldaferri, F; Graziani, C; Sgambato, A; Gerlitz, B; Papa, A; Ricci, R; Sans, M; Grinnell, B; Fedeli, G; Cittadini, A; Gasbarrini, A
TNF-alpha neutralizing antibody improves endothelial dysfunction in patients with Crohn's disease
2006-01-01 Armuzzi, A; Schinzari, F; de Pascalis, B; Mores, N; Gasbarrini, G; Melina, D; Cardillo, C
Treatment of nonresponder patients with chronic hepatitis C : To repeat or not to repeat? that is the question
2009-01-01 Aghemo, A.; Colombo, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients who are primary non-responders or intolerant to infliximab: A real life multi-center experience of compassionate use | 1-gen-2008 | Danese, S; Mocciaro, F; Guidi, L; Scribano, Ml; Comberlato, M; Vangeli, M; Pulitano, R; Manca, A; Armuzzi, A; Malesci, A; Prantera, C; Cottone, M | |
| Surveillance of Barrett's Esophagus Post Ablation: Is It Better to Use Jumbo Over Standard Biopsy Forceps? | 1-gen-2016 | Vennelaganti, S; Vennalaganti, P; Duvvuri, A; Lim, D; Jani, B; Repici, A; Ciscato, C; Spaggiari, P; Consolo, P; Di Leo, M; Mathur, S; Porter, J; Ferrara, E; Kennedy, K; Gupta, N; Sharma, P | |
| SWITCHING FROM INFLIXIMAB ORIGINATOR TO CT-P13 IS NOT RELATED TO INCREASED IMMUNOGENICITY IN IBD PATIENTS: A PROSPECTIVE CASE-CONTROL STUDY | 1-gen-2017 | Fiorino, G; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, Mf; Nagore, D; del Rio, L; Pascual, J; Martnez, A; Danese, S | |
| Synchronous Cancerization Increases Metastatic Potential in MSS Colorectal Cancers (CRCs) | 1-gen-2012 | Laghi, L; Fini, L; Basso, G; Bianchi, P; Delconte, G; Roncalli, M; Repici, A; Malesci, A | |
| Systemic chemotherapy and two-stage hepatectomy in patients with extensive bilobar colorectal liver metastases: Perioperative safety and survival | 1-gen-2007 | Chun, Ys; Vauthey, Jn; Ribero, D; Donadon, M; Eng, C; Brown, Td; Chang, Dz; Ho, L; Curley, Sa; Abdalla, Ek | |
| Targeting SMAD7 in Crohn's Disease by Mongersen: Therapeutic Revolution Under Way? | 1-gen-2015 | Danese, S; Fiorino, G; Peyrin-Biroulet, L. | |
| Telaprevir for hepatitis C re-treatment: an open door on a long and winding road. | 1-gen-2010 | Aghemo, A; Colombo, M. | |
| Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach! | 1-gen-2018 | Jaboli, F; Pouillon, L; Bossuyt, P; Danese, S; Peyrin-Biroulet, L | |
| The 5q31/IBD5 risk haplotype determines perianal phenotype in Crohn's disease | 1-gen-2002 | Armuzzi, A; Ahmad, T; De Silva, Ap; Ling, K; Cullen, S; Van Heel, D; Jewell, D | |
| The atypical chemokine receptor D6 controls intestinal inflammation and inflammation-associated colon cancer | 1-gen-2008 | Vetrano, S.; Borroni, E.; Bonecchi, R.; Correale, C.; Arena, V.; Fantini, M.; Malesci, A.; Vecchi, A.; Mantovani, A.; Locati, M.; Danese, S. | |
| THE EFFECTS OF VAGUS NERVE STIMULATION IN BIOLOGIC-REFRACTORY CROHN'S DISEASE: A PROSPECTIVE CLINICAL TRIAL | 1-gen-2018 | D'Haens, Gr; Cabrijan, Z; Eberhardson, M; van den Berg, Rm; Lowenberg, M; Fiorino, G; Danese, S; Levine, Ya; Chernoff, D | |
| The Golden Compass to the Depths | 1-gen-2016 | Carrara, S; Di Leo, M; Zerbi, A | |
| The impact of probiotics in antibiotic-associated diarrhea: A meta-analysis of placebo-controlled trials | 1-gen-2001 | Cremonini, F; Di Caro, S; Bartolozzi, F; Armuzzi, A; Santarelli, L; Gabrielli, M; Colasanti, S; Pola, P; Gasbarrini, G; Gasbarrini, A | |
| The intercellular adhesion molecule-1 polymorphisms in IBD | 1-gen-2002 | Li, Jh; Yang, Xs; Cullen, S; Lin, Kl; Armuzzi, A; Ahmad, T; Neville, Mj; Walton, R; Jewell, D | |
| The molecular classification of the clinical manifestations of Crohn's disease | 1-gen-2002 | Ahmad, T; Armuzzi, A; Bunce, M; Mulcahy-Hawes, K; Marshall, Se; Orchard, Tr; Crawshaw, J; Large, O; De Silva, A; Cook, Jt; Barnardo, M; Cullen, S; Welsh, Ki; Jewell, Dp | |
| The Prague Criteria Predict Response to Successful Endoscopic Eradication Therapy for Barrett's Esophagus With Dysplasia or Early Cancer: Results From an International, Multi-Center Consortium | 1-gen-2015 | Konda, Vj; Repici, A; Gupta, N; Vennalaganti, P; Seewald, S; Olyaee, Ms; Buckles, Dc; Muthineni, S; Brown, J; Parasa, S; Bansal, A; Sharma, P | |
| The PROSIT-BIO Cohort of the IG-IBD: A Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab BioSimilars | 1-gen-2016 | Fiorino, G; Manetti, N; Variola, A; Bossa, F; Rizzuto, G; Armuzzi, A; Massari, A; Ghione, S; Cantoro, L; Lorenzon, G; Fries, W; Annunziata, Ml; Costa, F; Terpin, Mm; Principi, M; Cortelezzi, Cc; Biancone, L; Amato, A; Occhipinti, P; Mazzuoli, S; Ardizzone, S; Di Girolamo, M; Alvisi, P; Meucci, G; Caserta, L; Saibeni, S; Petruzzzellis, C; Ronchetti, A; Cappello, M; Castiglione, F; Danese, S; Massella, A; Varvara, D; Orlando, A; Annese, V | |
| The thrombomodulin-activated protein C-endothelial protein C receptor pathway: A novel anti-inflammatory system in inflammatory bowel disease | 1-gen-2006 | Danese, S; Scaldaferri, F; Graziani, C; Sgambato, A; Gerlitz, B; Papa, A; Ricci, R; Sans, M; Grinnell, B; Fedeli, G; Cittadini, A; Gasbarrini, A | |
| TNF-alpha neutralizing antibody improves endothelial dysfunction in patients with Crohn's disease | 1-gen-2006 | Armuzzi, A; Schinzari, F; de Pascalis, B; Mores, N; Gasbarrini, G; Melina, D; Cardillo, C | |
| Treatment of nonresponder patients with chronic hepatitis C : To repeat or not to repeat? that is the question | 1-gen-2009 | Aghemo, A.; Colombo, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile